直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Advised on a patent revocation action relating to an antiepileptic drug*

Advised on a patent revocation action relating to an antiepileptic drug.

Related Professionals

Nessa Khandaker
Associate
London
+44 (0)20 7864 2828
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Unitary Patent System (UPS) and the Unified Patent Court (UPC)

Patent Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Biologics

*Matter handled prior to joining Finnegan.

Related Experiences

Advised a global life sciences company on (non-)infringement issues relating to a chemistry-related patent covering an anti-cancer drug for treating leukemias*

Advised a pulmonary drug delivery company on (non-)infringement issues relating to inhalers*

Advised on a trade mark infringement and passing off dispute relating to a global broadcaster at the High Court and validity dispute at the UKIPO*

Advised on and conducted enforcement action against the misuse of a major global retailer in domain names for third party websites*

Advised a biopharmaceutical company on patents covering a well-known biologic medicine for treating multiple types of cancer*

Advised a biotechnology company on patents covering a well-known biologic medicine for treating eye diseases*

Advised a global innovator pharma company in relation to enforcement issues surrounding its second medical use patent for a chemotherapy medication*

Advised a multinational tobacco company on the validity of patents related to next generation vaping products, and freedom to operate issues*

Advised a global investment firm on patent and life sciences regulatory aspects in respect of medicines for rare diseases and specialty care products*

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP